Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42
Ming Gao(East Tennessee State University), Mingzhi Zhang(Chinese Academy of Sciences), Shenglei Li(First Affiliated Hospital of Zhengzhou University), Xudong Zhang(Agricultural Genomics Institute at Shenzhen), Zhiwei Chang(First Affiliated Hospital of Zhengzhou University), Liying Liu(Zhengzhou People's Hospital)
Cited by 18
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression
|The Journal of Immunology|2015|187
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134